An investigation into the molecular basis of cancer comorbidities in coronavirus infection | Zendy

Facchiano Antonio | Zendy; Facchiano Francesco | Zendy; Facchiano Angelo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

An investigation into the molecular basis of cancer comorbidities in coronavirus infection

Author(s) -

Facchiano Antonio,

Facchiano Francesco,

Facchiano Angelo

Publication year - 2020

Publication title -

febs open bio

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.718

H-Index - 31

ISSN - 2211-5463

DOI - 10.1002/2211-5463.12984

Subject(s) - covid-19 , coronavirus , virology , medicine , cancer , comorbidity , betacoronavirus , disease , outbreak , infectious disease (medical specialty)

Five receptors/interactors of coronaviruses may play a key role in COVID‐19 comorbidities. They are expressed in almost any body district and, regardless of coronavirus infection, are associated with several diseases, including those most frequently cooccurring in COVID‐19 patients. Their expression is strongly altered in many cancers and at least three of them may be relevant markers in kidney, liver and thyroid cancers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research